Mucormycosis of Maxilla, as a Post Covid Complication in a Diabetic Patient, A Case Report

Abstract

The current pandemic for coronavirus disease (COVID-19) has caused great concern around the world, as it is capable of causing severe lung disease, and even death, in many patients. The people who develop more severe complications when infected by this disease are people with comorbidities such as Diabetes Mellitus (D.M.).The current medication used to manage the symptoms of COVID-19 includes systemic glucocorticoids, which suppress the immune system. Moreover, poorly controlled D.M. also predisposes to the development of infections by opportunistic germs.That is why people with COVID-19 and D.M. are more prone to develop opportunistic infections than others. In this case, a clinical case is reported about a diabetic patient diagnosed with COVID-19 who received corticosteroids in the treatment, later developing mucormycosis of the maxilla.